IVL Swedish Environmental Research Institute

ivl.se
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Self-declarations of environmental classification at Fass.se - Experiences from the reviewing process during 2019
IVL Svenska Miljöinstitutet.
IVL Svenska Miljöinstitutet.
IVL Svenska Miljöinstitutet.
IVL Svenska Miljöinstitutet.
2021 (engelsk)Rapport (Annet vitenskapelig)
Abstract [en]

Since 2005 Sweden has a unique environmental classification system for pharmaceutical products. It is a self-declaration system where each pharmaceutical company is responsible for their own environmental information, which is published on the open web-based portal www.Fass.se. Prior to publication the environmental risk assessments are reviewed by IVL Swedish Environmental Research Institute (IVL) as an independent, external part. The present report describes the experiences from the review process during the year 2019.

In 2019, environmental risk assessments (ERAs) were sent in for review 421 times. 63% of the reviewed assessments received the comment no remarks and were recommended to be published, whereas the other 37% were recommended to be corrected or needed to be corrected before publication. The number of unique substances that were published at Fass.se during 2019 was 315. Of these substances 43% were exempted from classification, 27% were classified regarding environmental risk, and 30% could not gain any classification due to lack of data.

The work of improving the review system is an on-going process. As a part of this work IVL performs studies and activities to increase the knowledge of pharmaceuticals in the environment. In 2018/2019 a model was developed for environmental assessment of pharmaceutical products, in regard to environmental risks related to emissions of Active Pharmaceutical Ingredient (API) from production processes and product carbon footprint in a life cycle perspective.

Abstract [sv]

Den här rapporten finns endast på engelska. Svensk sammanfattning finns i rapporten.

sted, utgiver, år, opplag, sider
IVL Svenska Miljöinstitutet, 2021.
Serie
B-rapport ; B2415
Emneord [sv]
läkemedel, fass, årsrapport, pharmaceutical, yearly report
Identifikatorer
URN: urn:nbn:se:ivl:diva-2764OAI: oai:DiVA.org:ivl-2764DiVA, id: diva2:1552210
Tilgjengelig fra: 2021-05-05 Laget: 2021-05-05 Sist oppdatert: 2021-05-05bibliografisk kontrollert

Open Access i DiVA

fulltekst(678 kB)89 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 678 kBChecksum SHA-512
7f5818fe63f90ee7eb552fa435fe6d71aab7dd310989dad18d444c29b496148bb5d24a83d5a986b4c17dd11e0a9ec2018e1070a9add75f3183968e807a20dd25
Type fulltextMimetype application/pdf

Søk i DiVA

Av forfatter/redaktør
Graae, LisetteÖrtlund, LindaMårdberg, PiaSjöblom, Ann
Av organisasjonen

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 89 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

urn-nbn

Altmetric

urn-nbn
Totalt: 94 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
v. 2.43.0